Press release distribution, EDGAR filing, XBRL, regulatory filings


Celgene and Acceleron Announce Luspatercept Achieved Primary and All Key Secondary Endpoints in Phase III 'BELIEVE' Study in Adults with Transfusion-Dependent Beta-Thalassemia )--Celgene Corporation and Acceleron Pharma Inc. today announced results from a phase III, randomized, double-blind, mul... )--Harris Williams & Co., a preeminent middle market investment bank focused on the advisory needs of clients worldwide for more than 25 years, announces that it ad... )--Ajax Health , a privately held clinical-stage platform company focused on developing medical technologies, announced today the closing of an oversubscri... )--Cactus, Inc. announced today that it has commenced an underwritten public offering of 10,000,000 shares of its Class A common stock... )--Shionogi & Co., Ltd. has announced that effective... )--Ares Management, L.P. announced today that it will report earnings for the ... (more)



from Biotech News